IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q1 2018 Holdings

Filed 2018-05-08 | 5 holdings | $132.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$48.1K2,279,78836.3%
Unum Therapeutics IncCOM903214104$37.3K3,361,53528.2%
Synlogic IncCOM87166L100$24.9K2,651,96318.8%
Spero Therapeutics Inc(SPRO)COM84833T103$19.6K1,376,96814.8%
Snap Inc(SNAP)CL A83304A106$2.4K150,1601.8%